Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial

14 references·15 citing·34 second hop

FromToDepth

this work references cited by second hop

References

1960A RATING SCALE FOR DEPRESSION32,812 cited
1979A New Depression Scale Designed to be Sensitive to Change13,964 cited
2016Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial2,196 cited
2016Why is depression more common among women than among men?1,746 cited
2016Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial1,696 cited
2018Psychedelics Promote Structural and Functional Neural Plasticity1,201 cited
2018Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial851 cited
2010The neurobiology of psychedelic drugs: implications for the treatment of mood disorders720 cited
2017Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms587 cited
2015Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report485 cited
2015Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression465 cited
2016Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years306 cited
2016Neuropharmacology of N,N-dimethyltryptamine

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

266 cited

2019A systematic study of microdosing psychedelics235 cited

Cited by

2020Persisting Reductions in Cannabis, Opioid, and Stimulant Misuse After Naturalistic Psychedelic Use: An Online Survey157 cited
2021Classic serotonergic psychedelics for mood and depressive symptoms: a meta-analysis of mood disorder patients and healthy participants137 cited
2020Low Doses of LSD Acutely Increase BDNF Blood Plasma Levels in Healthy Volunteers130 cited
2020Changes in inflammatory biomarkers are related to the antidepressant effects of Ayahuasca128 cited
2020Chronic pain and psychedelics: a review and proposed mechanism of action119 cited
2022The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT)112 cited
2019Therapeutic use of serotoninergic hallucinogens: A review of the evidence and of the biological and psychological mechanisms111 cited
2022Classic Psychedelic Drugs: Update on Biological Mechanisms109 cited
2021Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder91 cited
2023Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants89 cited
2022Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline88 cited
2022Psychedelics and Neural Plasticity: Therapeutic Implications82 cited
2024The Psychedelic Future of Post-Traumatic Stress Disorder Treatment80 cited
2023Serotonin 2A Receptor (5-HT 2A R) Agonists: Psychedelics and Non-Hallucinogenic Analogues as Emerging Antidepressants78 cited
2022Overcoming epistemic injustices in the biomedical study of ayahuasca: Towards ethical and sustainable regulation19 cited